로딩 중…
지수 로딩 중…
Macrogen, Inc.
038290· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩10,980+0.73%
2026-11-02
Financials
Valuation Metrics
Macrogen, Inc.'s Market Cap is ₩1190B. At end of 2025 it was ₩1829B. Ranked #1114 of 2,405 in KR market (top 46%), #579 of 1,627 on KOSDAQ (top 36%), #130 of 231 in Pharmaceuticals, Biotechnology & Life Sciences (top 56%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 119.04B KRW | KR#1,114/2,405 Sec#130/231 |
| Revenue | 201.62B KRW | KR#1,031/2,405 Sec#60/231 |
| Net Income | 8.71B KRW | KR#1,015/2,405 Sec#62/231 |
| Total Assets | 370.47B KRW | KR#912/2,405 Sec#55/231 |
| Net Assets | 171.22B KRW | KR#1,047/2,405 Sec#73/231 |
| Employees | 529 | KR#467/2,405 Sec#38/231 |
| Value | ||
| P/E | 13.67x | KR#1,044/2,405 Sec#63/231 |
| P/B | 0.70x | KR#1,196/2,405 Sec#69/231 |
| PEG | 0.00x | KR#50/2,405 Sec#3/231 |
| P/S | 0.59x | KR#1,083/2,405 Sec#54/231 |
| EV/EBITDA | 32.67x | KR#1,250/2,405 Sec#79/231 |
| FCF Yield | -10.87% | KR—/2,405 Sec—/231 |
| Profitability | ||
| ROE | 5.09% | KR#1,089/2,405 Sec#75/231 |
| ROA | 2.35% | KR#1,149/2,405 Sec#85/231 |
| Op. Margin | 2.45% | KR#1,319/2,405 Sec#94/231 |
| Revenue Growth | 23.00% | KR#496/2,405 Sec#47/231 |
| Earnings Growth | 4373.90% | KR#18/2,405 Sec#3/231 |
| Financial Health | ||
| Debt Ratio | 116.38% | KR#1,682/2,405 Sec#192/231 |
| Total Debt | 98.93B KRW | KR#730/2,405 Sec#46/231 |
| FCF | -12.94B KRW | KR#1,773/2,405 Sec#160/231 |
| Cash | 56.45B KRW | KR#689/2,405 Sec#38/231 |
| Current Ratio | 0.85x | KR#1,881/2,405 Sec#184/231 |
| Net Debt/EBITDA | 8.59x | KR#1,169/2,405 Sec#85/231 |
| Dividend | ||
| Div. Yield | 4.55% | KR#372/2,405 Sec#13/231 |
| Div. Growth | 66.67% | KR#178/2,405 Sec#6/231 |
| Performance | ||
| 1Y Return | -27.52% | KR#1,363/2,405 Sec#100/231 |
| 1M Return | -12.79% | KR#1,398/2,405 Sec#139/231 |
| From 52W High | -47.46% | KR#1,058/2,405 Sec#75/231 |
| 1Y MDD | -45.18% | KR#748/2,405 Sec#56/231 |
| Trading | ||
| Volume | 12,218 shares | KR#1,752/2,405 Sec#172/231 |
| Trading Value | 133.2M KRW | KR#1,317/2,405 Sec#146/231 |
| Foreign Own. | 4.13% | KR#1,017/2,405 Sec#92/231 |
| Per Share | ||
| EPS | 803 KRW | KR#809/2,405 Sec#57/231 |
| BPS | 15,793 KRW | KR#666/2,405 Sec#42/231 |
Company Info
동사는 1997년 설립된 정밀의학 생명공학기업으로 2000년 코스닥에 상장되었으며 2023년 유럽법인이 스위스, 일본 법인을 설립함. 유전체 분석, Oligo합성, Microarray 분석, 유전자변형 마우스 제작 등 유전체 서비스 제공하며 CES, NGS 두 분야로 사업 운영하고 있음. 주요 도시 지놈센터 거점을 통해 '$100 DNA 몸 설계도' 제공을 목표로 정밀 맞춤의학 실현에 앞장서고 있음. 마크로젠는 1997년에 설립되었으며 서울특별시 강남구에 본사를 두고 있습니다.